Immediate surgery can improve outcomes among women age 70 and older who are not receiving radiotherapy, data suggest.
Imlunestrant, given alone or in combination with abemaciclib, has demonstrated efficacy in patients with ER+, HER2- advanced breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback